State Action
CCAGW Urges California State Senate to Support Assemblyman Kiley's Amendment to Repeal AB 5
CCAGW urges California State Senate to support Assemblyman Kiley's amendment to repeal a bill that hurts gig economy workers.
CCAGW Urges California State Assembly to Support Assemblyman Kiley's Amendment to Repeal AB 5
CCAGW urges California State Assembly to support Assemblyman Kiley's amendment to repeal a bill that hurts gig economy workers.
CCAGW Urges Utah House of Representatives to Support HB 6005
CCAGW urges the Utah House of Representatives to vote for HB 6005: Cosmetology and Associated Professions Amendments
CCAGW Urges Utah House of Representatives to Support HB 6006
CCAGW urges the Utah House of Representatives to support HB 6006: Alcohol License and Permit Amendments
CCAGW Urges the Utah Senate to Support HB 6005
CCAGW Urges the Utah Senate to Support HB 6005: Cosmetology and Associated Professions Amendments
CCAGW Urges the Utah Senate to Support HB 6006
CCAGW Urges the Utah Senate to Support HB 6006: Alcohol License and Permit Amendments
CCAGW Urges California Assembly Appropriations Committee to Oppose SB 1410
CCAGW urges the California Assembly Appropriations Committee to oppose a bill that would defer rent payments.
CCAGW Urges California Senate Judiciary Committee to Oppose SB 1410
CCAGW urges the California Senate Judiciary Committee to oppose a bill that would defer rent payments.
CCAGW Urges Support for Deregulation Legislation in Ohio
CCAGW urges members of the House State and Local Government Committee to vote for legislation that would eliminate regulatory barriers for healthcare, education, and businesses to recover from the COVID-19 pandemic.
Minnesota - Oppose SF 1098
CCAGW urges the Minnesota House Minority Leader and his colleagues to oppose SF 1098, the Prescription Drug Transparency Act.
Minnesota - Oppose SF 1098
CCAGW urges Minnesota State legislators to oppose SF 1098, the Prescription Drug Transparency Act.
Minnesota - Oppose SF 1098
CCAGW urges Minnesota state senators to oppose SF 1098, the Prescription Drug Price Transparency Act.
